The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement
Phase of Trial: Phase IV
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Tolvaptan (Primary) ; Torasemide
- Indications Tricuspid valve insufficiency
- Focus Therapeutic Use
- 19 Dec 2016 Status changed from recruiting to completed.
- 17 Mar 2016 Status changed from active, no longer recruiting to recruiting, according to ClinicalTrials.gov record.
- 11 Jan 2016 New trial record